Form 8-K - Current report:
SEC Accession No. 0000950170-22-013150
Filing Date
2022-07-27
Accepted
2022-07-27 08:01:00
Documents
12
Period of Report
2022-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20220725.htm   iXBRL 8-K 54770
  Complete submission text file 0000950170-22-013150.txt   168906

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20220725_pre.xml EX-101.PRE 9443
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20220725.xsd EX-101.SCH 2454
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20220725_lab.xml EX-101.LAB 12798
6 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20220725_htm.xml XML 4526
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 221108884
SIC: 2836 Biological Products, (No Diagnostic Substances)